Fred has served on Analogic’s Board of Directors since 2007 as the company transitioned into a market leading, growth oriented medical technology company. Prior to joining Analogic, he served as the executive chairman and chief executive officer of Enovate Medical since 2015. He previously served as chief executive officer and director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013. Fred was also chairman of the board and chief executive officer of Urologix, Inc. from 2003 to 2008. Prior to joining Urologix, Fred served as president and chief executive officer of Marconi Medical Systems, a provider of advanced CT, MRI, and nuclear medicine imaging equipment, and following its acquisition by Royal Philips Electronics in 2001, led its integration into the Philips medical business. Previously, Fred held positions as president, chief operating officer, and board member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as president, chief operating officer, and board member of EG&G, Inc. (now PerkinElmer), a diversified technology company.
Fred earned a BS in mechanical engineering from University of Missouri-Rolla, an MS in mechanical engineering from University of Arizona, and a PhD in mechanical engineering from University of Missouri.
Mervat joined Analogic in 2005 as vice president of operations for ANRAD Corporation, an Analogic subsidiary. In 2006 she was named the company's president. Prior to joining ANRAD, Mervat served as president and CEO of ITF Optical Technologies, a designer and manufacturer of advanced photonics solutions. Mervat holds a bachelor of science degree in chemistry/physics from the American University in Cairo.
Mark joined Analogic in 2015. Before then, he was executive vice president and chief financial officer for AngioDynamics, a leading provider of medical, surgical, and diagnostic devices used for vascular access and the treatment of peripheral vascular disease, and for use in oncology and surgical settings. Prior to that, he served as senior vice president of administration and chief financial officer of Albany Molecular Research Incorporated, a global provider of contract research and manufacturing services to biotech and pharmaceutical companies. Before joining AMRI in 2004, Mark held various financial roles at Smith+Nephew and General Electric, both domestically and internationally. Mark received a bachelor of arts degree in international relations/economics from Colgate University.
John joined the Company in 2007. Before coming to Analogic, he was a principal at the law firm of Driggs, Hogg, & Fry Co., L.P.A. Before that, he was senior corporate counsel and intellectual property manager for Philips Medical Systems. John received his law degree from Cleveland-Marshall College of Law and both graduate and undergraduate degrees in electrical engineering from Case Western Reserve University. He is a named inventor on 10 U.S. patents.
Jim joined Analogic in 2008. Jim came to Analogic from Booz & Company, a leading global management consulting firm, where he served in the Operations Strategy Group for over eight years. Prior to Booz & Co, Jim worked for Ingersoll-Rand in both manufacturing and advanced engineering capacities. Jim’s education includes a bachelor of science degree in engineering from Lehigh University, a master of science degree in engineering from the Massachusetts Institute of Technology (MIT), and an MBA from MIT.
Before joining Analogic in 2017, Brooks was a senior medical device analyst for Piper Jaffrey, a leading investment bank and asset management firm. Prior to that he held leadership roles in marketing and business development at Urologix, a provider of urology medical devices. Brooks received a bachelor of science in business administration from the Boston University School of Management, with a concentration in economics and international finance.